Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
145.43
CNY
1.26%
Market Closed
Market Cap:
¥13.5B
Relative Value
The Relative Value of one
Beijing Hotgen Biotech Co Ltd
stock under the Base Case scenario is
19.75
CNY.
Compared to the current market price of 145.43 CNY,
Beijing Hotgen Biotech Co Ltd
is
Overvalued by 86%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
19.75
CNY
Overvaluation 86%
Multiples Across Competitors
Competitors Multiples
Beijing Hotgen Biotech Co Ltd Competitors
Beijing Hotgen Biotech Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
13.5B CNY | 31 | -52 | -48.9 | -48.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.2T USD | 418.7 | 4 960.4 | 1 454.7 | 2 922.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
213.3B USD | 4.8 | 31.9 | 22 | 29.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
153.5B USD | 6.2 | 42.5 | 23.4 | 35.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
81T KRW | 14.7 | 50.7 | 29.8 | 39.7 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36B CHF | 5.6 | 38.4 | 28.2 | 28.2 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
34.7B USD | 2.2 | 27 | 13.4 | 20.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
271B CNY | 6.1 | 18.1 | 18.2 | 18.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
37.5B USD | 5.4 | 28.8 | 21 | 24.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.9B USD | 7.1 | 33.4 | 24.1 | 26.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
22.6B USD | 7.3 | 34.8 | 22.5 | 28 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
